Fig. 4From: Transcriptional and free radical responses to LVAD therapyPDK4 is the key regulator of pyruvate entry into the Krebs cycle. Increased expression of PDK4 would inhibit or block entry of pyruvate into the Krebs cycle or oxidative metabolism. Our data suggests that this occurs in heart failure pre and post LVAD patientsBack to article page